跳至主要内容
临床试验/NCT04017364
NCT04017364已完成不适用

Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter

InnoRa GmbH12 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2019年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
InnoRa GmbH
入组人数
70
试验地点
12
主要终点
late lumen loss in-segment

研究概览

简要总结

To examine the treatment of coronary de-novo stenosis with a sirolimus coated balloon versus a paclitaxel coated balloon

详细描述

To examine the treatment of coronary de-novo stenosis with a sirolimus coated balloon versus a paclitaxel coated balloon. Prospective, multicenter, randomized, single-blind, 70 patients. Experimental intervention: Predilatation of coronary de-novo stenosis followed by a sirolimus coated SeQuent®SCB balloon (sirolimus 4.0 μg/mm²). Control intervention: Predilatation of coronary de-novo stenosis followed by a SeQuent®Please or SeQuent®Please Neo balloon (paclitaxel 3.0 μg/mm²). Follow-up per patient: 30 days telephone call; 6 months angiographic + 12 months. clinical follow up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical evidence of stable or unstable angina or a positive functional study
  • Patients with significant coronary de-novo stenosis (≥ 70% diameter stenosis or intermediate ≥ 50% to <70% diameter stenosis with positive functional test or symptom of ischemia)
  • Successful lesion preparation (no flow-limiting dissection or a residual stenosis > 30%)

排除标准

  • Acute myocardial infarction within the past 72 hours (STEMI or NSTEMI)
  • Intolerance and / or allergy to Sirolimus
  • Intolerance or allergy to Paclitaxel and/or the delivery matrix (main ingredient:
  • Patients with an ejection fraction of < 30 %
  • Reference vessel diameter (RVD) < 2.5 mm
  • Contraindication for whichever necessary accompanying medication

结局指标

主要结局

late lumen loss in-segment

时间窗: 6 months

angiographic minimal lumen diameter in-segment at 6 months minus minimal lumen diameter at baseline

次要结局

  • MACE(at 6 and at 12 months)
  • Procedural success(5 days)

研究者

发起方
InnoRa GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验